With the untapped market opportunities in oligonucleotides, drug developers are actively seeking help from partners who can provide them with trusted platform technologies, GMP-compliant analytical tools to help them generate robust, reproducible data, as well as CDMOs who can enable seamless tech transfer and scale-up.
The Oligonucleotides CMC & Analytical Development Summit isn't a tradeshow, it's an opportunity for you to have meaningful, 1-2-1 conversations to foster long-term partnerships, we would love to help you through this dedicated forum and position your brand in front of industry KOLs to pave the journey in front of us.
Get in touch to discuss your goals and objectives, and how we can work together for our next event with a tailored option to elevate your brand and thought leadership.
Why Partner?
Benefit from Market Intelligence
Expand your networking horizons by meeting oligonucleotide drug experts for networking, data sharing, and case-study analysis to match your solutions to the market
Meet and Network with Industry Pioneers
Promote your brand to powerhouses and newcomers alike, which in 2024 would have included, GSK, Sarepta, Takeda, Alloy Therapeutics, Biogen, and many more
Raise Brand Awareness and Generate Commercial Collaborations
Unleash the full potential of your brand that'll leave a lasting impression
Networking time with CXOs, VPs, and Directors of Discovery, Medicinal and Biological Chemistry
2024 PARTNERS
